Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1956 1
1965 1
1967 3
1968 2
1969 3
1971 2
1973 1
1976 1
1982 1
1983 1
1985 1
1986 4
1988 2
1989 5
1990 5
1991 3
1992 7
1993 7
1994 3
1995 3
1996 6
1997 6
1998 5
1999 1
2000 4
2001 8
2002 3
2003 5
2004 6
2005 8
2006 17
2007 8
2008 14
2009 10
2010 10
2011 18
2012 13
2013 19
2014 22
2015 23
2016 22
2017 27
2018 25
2019 12
2020 21
2021 33
2022 29
2023 25
2024 24
2025 1

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

431 results

Results by year

Filters applied: . Clear all
Page 1
Spanish COPD Guidelines (GesEPOC 2021): Non-pharmacological Treatment Update.
Cosío BG, Hernández C, Chiner E, Gimeno-Santos E, Pleguezuelos E, Seijas N, Rigau D, López-Campos JL, Soler-Cataluña JJ, Calle M, Miravitlles M, Casanova C; en nombre del equipo de trabajo de GesEPOC 2021. Cosío BG, et al. Among authors: casanova c. Arch Bronconeumol. 2022 Apr;58(4):345-351. doi: 10.1016/j.arbres.2021.08.010. Epub 2021 Sep 17. Arch Bronconeumol. 2022. PMID: 35312554 Free article. English, Spanish.
Atezolizumab plus bevacizumab and chemotherapy for metastatic, persistent, or recurrent cervical cancer (BEATcc): a randomised, open-label, phase 3 trial.
Oaknin A, Gladieff L, Martínez-García J, Villacampa G, Takekuma M, De Giorgi U, Lindemann K, Woelber L, Colombo N, Duska L, Leary A, Godoy-Ortiz A, Nishio S, Angelergues A, Rubio MJ, Fariñas-Madrid L, Yamaguchi S, Lorusso D, Ray-Coquard I, Manso L, Joly F, Alarcón J, Follana P, Romero I, Lebreton C, Pérez-Fidalgo JA, Yunokawa M, Dahlstrand H, D'Hondt V, Randall LM; ENGOT-Cx10–GEICO 68-C–JGOG1084–GOG-3030 Investigators. Oaknin A, et al. Lancet. 2024 Jan 6;403(10421):31-43. doi: 10.1016/S0140-6736(23)02405-4. Epub 2023 Dec 1. Lancet. 2024. PMID: 38048793 Clinical Trial.
Prevalence and Determinants of COPD in Spain: EPISCAN II.
Soriano JB, Alfageme I, Miravitlles M, de Lucas P, Soler-Cataluña JJ, García-Río F, Casanova C, Rodríguez González-Moro JM, Cosío BG, Sánchez G, Ancochea J. Soriano JB, et al. Among authors: casanova c. Arch Bronconeumol (Engl Ed). 2021 Jan;57(1):61-69. doi: 10.1016/j.arbres.2020.07.024. Epub 2020 Sep 17. Arch Bronconeumol (Engl Ed). 2021. PMID: 32950310 English, Spanish.
Comorbidities and risk of mortality in patients with chronic obstructive pulmonary disease.
Divo M, Cote C, de Torres JP, Casanova C, Marin JM, Pinto-Plata V, Zulueta J, Cabrera C, Zagaceta J, Hunninghake G, Celli B; BODE Collaborative Group. Divo M, et al. Among authors: casanova c. Am J Respir Crit Care Med. 2012 Jul 15;186(2):155-61. doi: 10.1164/rccm.201201-0034OC. Epub 2012 May 3. Am J Respir Crit Care Med. 2012. PMID: 22561964
Spanish COPD Guidelines (GesEPOC) 2021 Update Diagnosis and Treatment of COPD Exacerbation Syndrome.
Soler-Cataluña JJ, Piñera P, Trigueros JA, Calle M, Casanova C, Cosío BG, López-Campos JL, Molina J, Almagro P, Gómez JT, Riesco JA, Simonet P, Rigau D, Soriano JB, Ancochea J, Miravitlles M; en representación del grupo de trabajo de GesEPOC 2021. Soler-Cataluña JJ, et al. Among authors: casanova c. Arch Bronconeumol. 2022 Feb;58(2):159-170. doi: 10.1016/j.arbres.2021.05.011. Epub 2021 May 26. Arch Bronconeumol. 2022. PMID: 34172340 Free article. English, Spanish.
Spanish COPD Guidelines (GesEPOC) 2021: Updated Pharmacological treatment of stable COPD.
Miravitlles M, Calle M, Molina J, Almagro P, Gómez JT, Trigueros JA, Cosío BG, Casanova C, López-Campos JL, Riesco JA, Simonet P, Rigau D, Soriano JB, Ancochea J, Soler-Cataluña JJ. Miravitlles M, et al. Among authors: casanova c. Arch Bronconeumol. 2022 Jan;58(1):69-81. doi: 10.1016/j.arbres.2021.03.005. Epub 2021 Mar 17. Arch Bronconeumol. 2022. PMID: 33840553 Free article. English, Spanish.
Sporadic retromammary schwannoma.
Casanova C, Gaio R, Pereira da Silva N, Abreu IC. Casanova C, et al. BMJ Case Rep. 2022 Dec 21;15(12):e253626. doi: 10.1136/bcr-2022-253626. BMJ Case Rep. 2022. PMID: 36543368 Free PMC article. No abstract available.
Post-radiation uterine rhabdomyosarcoma.
Casanova C, Madeira JIM, Pereira da Silva N, Antunes C. Casanova C, et al. BMJ Case Rep. 2024 Jan 24;17(1):e258853. doi: 10.1136/bcr-2023-258853. BMJ Case Rep. 2024. PMID: 38272523 No abstract available.
Carboplatin and paclitaxel plus avelumab compared with carboplatin and paclitaxel in advanced or recurrent endometrial cancer (MITO END-3): a multicentre, open-label, randomised, controlled, phase 2 trial.
Pignata S, Scambia G, Schettino C, Arenare L, Pisano C, Lombardi D, De Giorgi U, Andreetta C, Cinieri S, De Angelis C, Priolo D, Casanova C, Rosati M, Greco F, Zafarana E, Schiavetto I, Mammoliti S, Cecere SC, Salutari V, Scalone S, Farolfi A, Di Napoli M, Lorusso D, Gargiulo P, Califano D, Russo D, Spina A, De Cecio R, Chiodini P, Perrone F; MITO investigators. Pignata S, et al. Among authors: casanova c. Lancet Oncol. 2023 Mar;24(3):286-296. doi: 10.1016/S1470-2045(23)00016-5. Epub 2023 Feb 14. Lancet Oncol. 2023. PMID: 37052965 Clinical Trial.
431 results